Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PERK

protein kinase R-like endoplasmic reticulum kinase (PERK), inositol-requiring kinase 1 (IRE1) and activating transcription factor 6 (ATF6). Consequently, the harmful stimuli from the ER stress transducers induce apoptosis and autophagy, which share several crosstalks and eventually decide the cell fate.

Zotatifin
T172962098191-53-6
Zotatifin (eFT226) is a selective eIF4A inhibitor with antiviral and anticancer activities, blocking tumor growth driven by receptor tyrosine kinases and inhibiting Sox4 translation, inducing apoptosis.
  • $1,090
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Rocaglamide
TQ013184573-16-0
Rocaglamide (Roc-A), isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells.
  • $166
In Stock
Size
QTY
TargetMol | Inhibitor Hot
GSK2606414
T26141337531-36-8
GSK2606414 is a cell-permeable and orally active protein kinase R-like endoplasmic reticulum kinase(PERK)inhibitor with IC50 of 0.4 nM. GSK2606414 inhibits PERK activation in cells and suppresses the growth of human tumor xenografts in mice.
  • $61
In Stock
Size
QTY
TargetMol | Citations Cited
GCN2iB
T113752183470-12-2
GCN2iB is an ATP-competitive inhibitor of serine/threonine protein kinase, stress-responsive kinase (GCN2), with IC50 of 2.4 nM.
  • $77
In Stock
Size
QTY
TargetMol | Citations Cited
SHP099
T35641801747-42-1
SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
ATPγS tetralithium salt
T2259293839-89-5In house
ATPγS tetralithium salt is a good substrate for RNA-stimulated nucleotide hydrolysis and RNA unwinding activity of eIF4A.
  • $67
In Stock
Size
QTY
CCT020312
T14902324759-76-4In house
CCT020312 (0-9 µM, 24 h) treatment of medium HT29 cells for 24 h resulted in a concentration-dependent loss of P-S608-pRB signaling with linear response values between 1.8 and 6.1 µM.
  • $56
In Stock
Size
QTY
ISRIB (trans-isomer)
T61831597403-47-8
ISRIB (trans-isomer) is a potent inhibitor of PERK (IC50=5 nM) that restores protein translation and prevents SG formation in the presence of P-eIF2α.
  • $31
In Stock
Size
QTY
eIF4A3-IN-1
T111702095486-67-0
eIF4A3-IN-1 is a selective and potent inhibitor of eukaryotic initiation factor 4A3 (eIF4A3) with an IC50 value of 0.26 μM. eIF4A3-IN-1 inhibits cytosolic nonsense-mediated RNA decay at high concentrations.
  • $145
In Stock
Size
QTY
BTdCPU
T71501257423-87-2
BTdCPU is a potent activator of heme-regulated eIF2α kinase (HRI) . BTdCPU promotes eIF2α phosphorylation and induced apoptosis in resistant cell.
  • $148
In Stock
Size
QTY
TargetMol | Citations Cited
BTM-3528
T788752054998-45-5In house
BTM-3528 is an activator of the mitochondrial protease OMA1 with anticancer activity.BTM-3528 activates the ISR via the mitochondrial protease OMA1, inducing OMA1-dependent cleavage of DELE1 and OPA1 and mitochondrial fragmentation.BTM-3528 induces cell growth arrest and apoptosis.
  • $485 TargetMol
In Stock
Size
QTY
GCN2-IN-7
T636992396465-33-9In house
GCN2-IN-7 is an orally active, potent and selective inhibitor of the environmental sensing protein GCN2 with anti-tumor activity and can be used to study melanoma.
  • $313
In Stock
Size
QTY
HC-5404
T865452247396-91-2
HC-5404 is a novel, potent and highly selective PERK (Protein kinase RNA-like Endoplasmic Reticulum Kinase) inhibitor, blocking the activation of the PERK pathway, which in turn inhibits the endoplasmic reticulum stress response signaling pathway, thereby exerting anti-tumor effects, and can be used to treat advanced solid tumors and renal cell Cancer.
  • $179
In Stock
Size
QTY
DNL343
T788762278265-85-1In house
DNL343 is a selective and potent eIF2B activator that crosses the blood-brain barrier and inhibits the assembly of stress granules (SGs) induced by the C9ORF72 dipeptide repeats. DNL343 may be useful in the study of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS).
  • $148 TargetMol
In Stock
Size
QTY
2BAct
T91492143542-28-1
2BAct is a novel eif2b activator, preventing neurological defects caused by a chronic integrated stress response
  • $53
In Stock
Size
QTY
4EGI-1
T2665315706-13-9
4EGI-1, a competitive eIF4E eIF4 g interaction inhibitor, binds to eIF4E(KD=25 μM).
  • $37
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
GCN2-IN-1
T113731448693-69-3In house
GCN2-IN-1 (A-92) is an effective GCN2 inhibitor and can be utilized in cancer research as a chemotherapeutic agent.
  • $67
In Stock
Size
QTY
ISRIB
T2027548470-11-7
ISRIB is a potent and selective PERK inhibitor.
  • $48
In Stock
Size
QTY
TargetMol | Citations Cited
GSK2656157
T26541337532-29-2
GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Salubrinal
T3045405060-95-9
Salubrinal, a phosphatases (PP1) inhibitor(IC50=1.7 μM), exhibits function on the eukaryotic translation initiation factor 2 subunit (eIF2α).
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
Briciclib
T3207865783-99-9
Briciclib (ON 014185) is a small molecule that inhibits cyclin D1 accumulation in Y cells.
  • $39
In Stock
Size
QTY
Takeda-6d
T224361125632-93-0
Takeda-6d, a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits B-RAF and VEGFR2 with IC50 of 7.0nM and 2.2nM.
  • $98
In Stock
Size
QTY
BAY 2965501
T730532732902-08-6
BAY 2965501 is a potent and selective diacylglycerol kinase zeta (DGKζ) inhibitor that induces pERK activation, and it can be utilized in cancer research.
  • $84
In Stock
Size
QTY
Vaccarin
T388153452-16-7
Vaccarin is a major flavonoid glycoside in Vaccariae semen, its biotransformation pathways involves methylation, hydroxylation, glycosylation and deglycosylation.
  • $44
In Stock
Size
QTY